Molecular basis of JAK2 H608Y and H608N mutations in the pathology of acute myeloid leukemia
- 15 December 2022
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 229, 247-259
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The effects of R683S (G) genetic mutations on the JAK2 activity, structure and stabilityInternational Journal of Biological Macromolecules, 2013
- Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617FNature Structural & Molecular Biology, 2012
- JAK inhibitors for myeloproliferative neoplasms: clarifying facts from mythsBlood, 2012
- The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signalingNature Structural & Molecular Biology, 2011
- Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitorsHaematologica, 2011
- The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitorBlood, 2006
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005
- Autoinhibition of Jak2 Tyrosine Kinase Is Dependent on Specific Regions in Its Pseudokinase DomainMolecular Biology of the Cell, 2003
- Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factorProceedings of the National Academy of Sciences, 2000
- CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsJournal of Computational Chemistry, 1983